1. Home
  2. DYAI vs NUKK Comparison

DYAI vs NUKK Comparison

Compare DYAI & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • NUKK
  • Stock Information
  • Founded
  • DYAI 1979
  • NUKK 2013
  • Country
  • DYAI United States
  • NUKK United States
  • Employees
  • DYAI N/A
  • NUKK N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • NUKK Blank Checks
  • Sector
  • DYAI Health Care
  • NUKK Finance
  • Exchange
  • DYAI Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • DYAI 30.2M
  • NUKK 29.4M
  • IPO Year
  • DYAI 2004
  • NUKK N/A
  • Fundamental
  • Price
  • DYAI $0.85
  • NUKK $4.29
  • Analyst Decision
  • DYAI Strong Buy
  • NUKK
  • Analyst Count
  • DYAI 1
  • NUKK 0
  • Target Price
  • DYAI $6.00
  • NUKK N/A
  • AVG Volume (30 Days)
  • DYAI 233.6K
  • NUKK 241.7K
  • Earning Date
  • DYAI 08-13-2025
  • NUKK 09-10-2025
  • Dividend Yield
  • DYAI N/A
  • NUKK N/A
  • EPS Growth
  • DYAI N/A
  • NUKK N/A
  • EPS
  • DYAI N/A
  • NUKK N/A
  • Revenue
  • DYAI $3,554,344.00
  • NUKK N/A
  • Revenue This Year
  • DYAI $22.56
  • NUKK N/A
  • Revenue Next Year
  • DYAI $30.95
  • NUKK N/A
  • P/E Ratio
  • DYAI N/A
  • NUKK N/A
  • Revenue Growth
  • DYAI 57.59
  • NUKK N/A
  • 52 Week Low
  • DYAI $0.77
  • NUKK $1.30
  • 52 Week High
  • DYAI $2.20
  • NUKK $78.32
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 35.69
  • NUKK 23.80
  • Support Level
  • DYAI $0.77
  • NUKK $5.03
  • Resistance Level
  • DYAI $0.98
  • NUKK $6.25
  • Average True Range (ATR)
  • DYAI 0.09
  • NUKK 0.70
  • MACD
  • DYAI -0.03
  • NUKK -0.13
  • Stochastic Oscillator
  • DYAI 15.09
  • NUKK 9.65

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: